Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib and HMA as a Bridge to Transplant in Accelerated and Blast Phase MPN
NCT07148947Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of pacritinib in Myeloproliferative Neoplasm (MPN), sponsored by University of Washington. Started Mar 2026; status: recruiting.
02
Drugs
pacritinib
03
Conditions
Myeloproliferative Neoplasm (MPN)
Beyond the preview
Go deeper on NCT07148947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148947.